acute l Flashcards

(67 cards)

1
Q

The peak inci
dence of __in children is between 2 and 5 years of age.

A

ACUTE LYMPHOBLASTIC LEUKEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

, there may be a large mass in the mediastinum
leading to compromise of regional anatomic structures.

A

T cell ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bone pain, mucocutaneous bleeding

A

B cell ALL`

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

most common type of lymphoblast seen

A

small lymphoblast (1.0 to
2.5 times the size of a normal lymphocyte)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ALL cells can be confused with cells in

A

AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

are the strongest predic
tor of adverse treatment outcomes for children and adults

A

Chromosomal translocations are the strongest predic
tor of adverse treatment outcomes for children and adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mutations involving the NOTCH1 gene,

A

T-ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

has the worst prog
nosis among ALLs.

A

B-lymphoblastic leukemia/
lymphoma with the t(9;22)(q34;q11.2);BCR-ABL1 mutation
(Philadelphia chromosome–positive ALL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

, which has shown success in treating chronic
myeloid leukemia,

A

Imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

in B-lymphoblastic leukemia/
lymphoma is common in childhood B-ALL,

A

Hyperdiploidy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

is a
group of metabolic complications that can occur in patients
with malignancy, most notably lymphomas and leukemias, with
and without treatment of the malignancy

A

Tumor lysis syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tumor lysis syndrome is characterized by

A

hyperkalemia,
hyperphosphatemia, hyperuricemia and hyperuricosuria, and
hypocalcemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

AML with this translocation has myeloblasts with dysplastic granular cytoplasm, Auer rods, and some maturation

A

Acute myeloid leukemia with t(8;21)(q22;q22.1);RUNX1/
RUNX1T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)
(p13.1;q22);CBFB-MYH11.

A
  • Myeloblasts, monoblasts, and promyelocytes IN Pb and bm along with eosinp[hilia with dysplastic changes
  • central nervous system is a common site for relapse
  • remission rate is good, but only one half of
    patients are cured.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

characterized by a differentiation block
at the promyelocytic stage.

A
  • Acute promyelocytic leukemia with PML-RARA.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Detection of the 15;17 translocation is sufficient for
diagnosis regardless of blast count

A

Acute promyelocytic leukemia with PML-RARA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

their procoagulant activity initiates
disseminated intravascular coagulation; however, thromboem
bolic events may occur at presentation and during treatment

A

Acute promyelocytic leukemia with PML-RARA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

“butterfly” or “coin-on-coin” nucleus,

A

Acute promyelocytic leukemia with PML-RARA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

PML RARA

A

Treatment
includes all-trans-retinoic acid (ATRA) and arsenic trioxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

induces differentiation of
the malignant promyelocytes

A

atra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

is a rare leukemia (6% of AML cases) that presents with an
increase in monoblasts and immature monocytes

A

Acute myeloid leukemia with t(9;11)(p22;q23);KMT2A (MLL)
MLLT3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Typically this disease occurs in children and may be associated
with gingival and skin involvement and/or disseminated intravas
cular coagulation.

A

Acute myeloid leukemia with t(9;11)(p22;q23);KMT2A (MLL)
MLLT3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

a,l with myodeplasia-related changes are has specific MDS-associated cytogenetic abnormality except

A

del(9q).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

There must also be absence of AML with recurrent genetic ab
normalities, NPM1 and biallelic mutation of CEBPA

A

Acute Myeloid Leukemia with Myelodysplasia-Related
Changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
-rearranged is more common in very young infants and translocation may occur in the utero (has very poor prognosis)
t(v;11q23);KMT2A(MLL)
26
– common in children accounting for 25% of cases (more than 46 chromosomes) w/ favorable prognosis
Hyperdiploidy
27
– less than 46 chromosomes (poor prognosis)
Hypodiploidy
28
derived from a B cell progenitor rather than hematopoietic stem cells
t(12;21) (p13;q22);ETV6-RUNX1 translocation – derived from a B cell progenitor rather than hematopoietic stem cells
29
rare clinically aggressive tumor derived from precursors of plasmacytoid dendritic cells. skin lesions and may ultimately progress to involve peripheral blood and bone marrow
Blastic Plasmacytoid Dendritic Cell Neoplasm
30
 refers to extramedullary proliferation of blasts of one or more myeloid lineages that disrupts tissue architecture.
Myeloid Sarcoma
31
Fiftyfold increased incidence of AML during the first 5 years of life
Myeloid Proliferation related to Down Syndrome
32
 Similar to FAB M2
1. t(8;21)(q22;q22.1) – RUNX1/RUNX1T1 mutation
33
 Myeloblasts with dysplastic granular cytoplasm, Auer rods  BM eosinophilia
t(8;21)(q22;q22.1) – RUNX1/RUNX1T1 mutation
34
 Eosinophilia with dysplastic changes in the BM  High incidence of extramedullary disease  CNS is a common site for relapse  Favorable prognosis
Inv(16)(p13.1q22) / t(16;16) – CBFB-MYH11
35
Differentiation block at the promyelocytic stage (hypergranular with Auer rods)
APML with PML-RARA
36
“butterfly” or “coin-on-coin” nucleus
PML with PML-RARA
37
faggot cells)
Acute Promyelocytic Leukemia (APL; FAB M3)
38
CD13 and CD33 positive
Acute Promyelocytic Leukemia (APL; FAB M3)
39
inc in monoblasts and immature monocytes
t(9;11)(p22;q23) – KMT2A
40
 Motile blast cells with pseudopodia  Associated with gingival and skin involvement, DIC
t(9;11)(p22;q23) – KMT2A
41
20% blasts + multilineage dysplasia + history of MDS or MDS/MPN or MDS-associated cytogenetic abnormality except del(9q)
Acute Myeloid Leukemia with Myelodysplasia-related
42
M0- AML with Minimal Differentiation
 No Auer rods  No clear evidence of cellular maturation  Negative results with Myeloperoxidase and Sudan Black B
43
 Have Auer rods (fused primary granules)  90% of nonerythroid cells in the bone marrow (marrow myeloblast) Fewer than 10% of WBC show maturation to promyelocte stage or beyond
M1- AML without Maturation
44
Presents with greater than 20% blasts, at least maturing cells of neutrophil lineage  Fewer than 20% precursors with m
M2- AML with Maturation
45
may have Auer rods; chromosome abnormality t(8;21)
M2
46
(+) CD13, CD33, CD65, CD11b, CD15
M2- AML with Maturation
47
pan myeloid markers)
CD13 and CD33 positive (
48
t(15;17)- results in fusion between PML gene and retinoic acid alpha
M3- Acute Promyelocytic Leukemia
49
Most aggressive of acute leukemia with severe bleeding tendency
M3
50
Promyelocytes- Predominating cell type
M3
51
Presence of myeloid and monocytoid cells in PBS and BM
M4
52
Positive for the myeloid antigens CD13 and CD33 and the monocytic antigens CD14, CD4, CD11b, CD11c, CD64, and CD36.
M4
53
 FAB M5a - most common in children with >80% monoblasts in the bone marrow  FAB M5B - middle-aged adults with <80% monoblasts in the bone marrow.
FAB M5a vsFAB M5b
54
These cells are CD14+, CD4+, CD11b+, CD11c+, CD36+, CD64+, and CD68+
M5
55
Also referred to as erythremic myelosis or Di Guglielmo’s syndrome
7. M6- Pure Erythroid Leukemia/Erythroleukemia
56
Chr 5 and 7
M6
57
 Proliferation of both immature granulocytic and erythrocytic cell types  Megaloblastoid erythropoiesis  Nucleated RBCs in PB- >50% of the total number of nucleated cells  Ringed sideroblasts, Howell-Jolly bodies are present
M6
58
proliferation of megakaryoblasts and atypical megakaryocytes in BM
M7
59
Dx requires- at least 20% blasts, of which at least 50% must be of megakaryocyte origin
M7
60
 Dry tap; pancytopenia with thrombocytosis  Usually have cytopenias  With Dysplastic features
M7
61
CD41, CD42, and CD61 (platelet markers) positive
M7
62
Associated with lytic bone lesions and hyperhistaminemia
ACUTE BASOPHILIC LEUKEMIA
63
BM → hypercellular with diffusely fibrotic stroma, inc cell precursors, dysplastic blasts
ACUTE PANMYELOSIS WITH MYELOFIBROSIS
64
Extramedullary proliferation of blasts of one or more myeloid lineages that disrupts tissue architecture
MYELOID SARCOMA
65
Transient myeloproliferative disorder (TMD) - associated with GATA1 mutations
AML RELATED TO DOWN SYNDROME
66
Enzyme found in the primary granules of granulocytic cells.
Myeloperoxidase
67
Differentiate myeloblasts and neutrophilic granulocytes from cells of monocytic origin
Esterases